Immuneering | 4:持股变动声明-高管 Morales Mallory
Immuneering | 4:持股变动声明-董事 Schall Thomas J.
Immuneering | 4:持股变动声明-董事 Feinberg Peter
Immuneering | 4:持股变动声明-董事 KEATING LAURIE
Immuneering | 4:持股变动声明-董事 CARPENTER ROBERT J
Immuneering | 4:持股变动声明-董事 BERMAN ANN E
Immuneering | 4:持股变动声明-董事 HAUSMAN DIANA
Immuneering | 4:持股变动声明-高管 Bookman Michael
Immuneering | 4:持股变动声明-高管 Brakewood Harold Eugene
Immuneering | 4:持股变动声明-高管 Neufeld Leah R
Immuneering | 4:持股变动声明-高管 Morales Mallory
Immuneering | SC 13G/A:超过5%持股股东披露文件(修正)-Cormorant Asset Management, LP(5.81%),Bihua Chen(5.81%)等
Immuneering | SC 13G/A:超过5%持股股东披露文件(修正)-T. ROWE PRICE ASSOCIATES, INC.(3.1%)
Immuneering | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(4.7%)
Immuneering | 4:持股变动声明-股东 Cormorant Asset Management, LP
Immuneering | SC 13G/A:超过5%持股股东披露文件(修正)-Merrin Investors LLC(9.46%)
Immuneering | 4:持股变动声明-董事 Schall Thomas J.
Immuneering | 4:持股变动声明-董事 Feinberg Peter
Immuneering | 4:持股变动声明-高管 Brakewood Harold Eugene
Immuneering | 4:持股变动声明-高管 Morales Mallory
暂无数据
暂无数据